Surgical treatment of lipodystrophy associated with HIV-infection: Conclusions of a multidisciplinary meeting;Tratamiento quirúrgico de la lipodistrofia asociada a la infección por VIH. Conclusiones de una reunión multidisciplinar

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 25, Issue 5, 2007, Pages 324-328

  Moreno, Santiago ^a   Martínez, Esteban ^b   Miralles, Celia ^c   Negredo, Eugenia ^d   González, Vicente ^d   Del Pino, Vicente ^e   Arévalo, José M ^e   Aja, Azucena ^f   De Benito, D Emilio ^g  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL XERAL CALDE   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e Cirujano Plástico

^f Fundación FIT   (Spain)

^g NONE

Author keywords

Antiretroviral therapy; HIV; Lipoaccumulation; Lipoatrophy; Lipodystrophy

Indexed keywords

CONFERENCE PAPER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; LIPOSUCTION; MEDICAL SPECIALIST; PATIENT CARE; QUALITY OF LIFE; SURGEON; TREATMENT INDICATION; ULTRASOUND;

EID: 34547640301     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13102268     Document Type: Conference Paper

References (22)

1. Carr A, Samaras K, Burton S, LawM, Freund J, Chisholm, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12:F51-F8.
2. Viraben R, Aquilina C. Indinavir-associated lipodystrophy. AIDS. 1998;12:F37-F9.
3. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study. Lancet. 1999;353:2093-9.
4. Polo R, Galindo MJ, Martínez E, Álvarez J, Arévalo JM, Asensi V, et al. Recomendaciones de GEAM/SPNS sobre el manejo de las alteraciones metabólicas y morfológicas en los pacientes con infección por VIH. Enferm Infec Microbiol Clin. 2006;24:96-117.
5. Lichtenstein KA, Ward DJ, Moorman AC, Delaney KM, Young B, Palella FJ Jr, et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS. 2001;15:1389-98.
6. Lichtenstein KA, Delaney KM, Armon C, Ward DJ, Moorman AC, Wood KC, et al; HIV Outpatient Study Investigators. Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients. J Acquir Immune Defic Syndr. 2003;32:48-56.
7. Martínez E, Mocroft A, García-Viejo MA, Pérez-Cuevas JB, Blanco JL, Mallolas J, et al. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: A prospective cohort study. Lancet. 2001;357:592-8.
8. Marín A, Casado JL, Aranzábal L, Moya J, Antela A, Dronda F, et al. Validation of a specific questionnaire on psychological and social repercussions of the lipodistrophy síndrome in HIV-infected patients. Qual Life Res. 2006;15:767-75.
9. Marín A, Casado JL, Aranzábal L, et al. Social isolation and stigma in HIV-infected patients with lipodystrophy syndrome. AIDS Care 2007 (en prensa).
10. Fontdevilla J, Milinkovic A, Martínez E, Sik Yoon T, Gatell JM, Serra JM. Treatment of facial lipoatrophy by injection of autologous adipose tissue. Antivir Ther. 2003;8:L76 (abstract 113).
11. Guaraldi G, Orlando G, De Facio D, Vigo M, De Lorenzi I, Rottino A, et al. Autologous fat transfer for the treatment of HIV-related face lipoatrophy: a long follow-up experience. Antivir Ther. 2004;9:L50 (abstract 87).
12. a. ed. Fundación Wellcome España. Madrid; 2003. p. 730-42.
13. Casavantes LC, Gottlieb M. Bio-Alcamid, a high-volume injectable prosthesis for facial reconstruction in HIV-related lipoatrophy: report on 100 patients. Antivir Ther. 2004;9:L37.
14. Serra MS, Oyafuso LK. Soft tissue augmentation with polymethymethacrylate (PMMA) for correction of Lipodystrophy related body fat atrophy. Antivir Ther. 2004;9:L31.
15. Christensen LH, Breiting V, Aasted A, Jorgensen A, Kebuladze I. Long term effects of polyacrylamide hydrogel in human breast tissue. Plast Reconstr Surg. 2003;101:1883-90.
16. Polo R, Ortiz M, Babe J, Martínez S, Madrigal P, González-Muñoz M. The effects of polylactic acid in the therapy for the lipoatrophy of the face. Antivir Ther. 2001;6 Suppl 4:68.
17. Del Pino V, Arévalo JM, Moreno S, Dronda F. Successful surgical therapy with polyvinyl gel microspheres of severe facial lipoatrophy: results after one year of follow up. Antivir Ther. 2001;6:74.
18. Fontdevila J, Martínez E, Rubio-Murillo JM, Milinkovic A, Serra-Renom JM, Gatell JM. A practical classification for the surgical filling of facial lipoatrophy. 7th Intl Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 13-16 November 2005, Dublin, Ireland. Abstract 41.
19. Arévalo JM, Del Pino V. Reconstruction of the buttocks in adult patients with chronic HIV-1 infection by means of submuscular anatomical implants of cohesive silicone gel. Nutrition and Metabolic. Disorders in HIV Infection. 2003;2:250-6.
20. Wolfort FG, Cetrulo CL, Nevarre DR. Suction-assisted lipectomy for lipodystrophy syndromes attributed to HIV-protease inhibitor use. Plast Reconstr Surg. 1999;104:1814-20.
21. White DJ. Ultrasound assisted liposuction in 2002. En: Operatives Techniques in Plastic and Reconstructive Surgery. 2002;8:133-9.
22. Arévalo JM, Del Pino V. Ultrasound assisted liposuction in adult patients with HIV-1 associated Lipodystrophy syndrome. Nutrition and Metabolic Disorders in HIV Infections. 2003;2:98-105.